STOCK TITAN

Hinge Health (HNGE) CFO uses 9,986 shares to cover tax obligations

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge reported a routine tax-withholding transaction involving 9,986 shares of Class A common stock at $56.21 per share. These shares were relinquished and cancelled so the company could cover his federal and state tax obligations from vesting restricted stock units. Following this disposition, he directly holds 435,400 shares of Class A common stock.

Positive

  • None.

Negative

  • None.
Insider Budge James
Role Chief Financial Officer
Type Security Shares Price Value
Tax Withholding Class A Common Stock 9,986 $56.21 $561K
Holdings After Transaction: Class A Common Stock — 435,400 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares disposed for tax withholding 9,986 shares Class A Common Stock, tax-withholding disposition
Disposition price per share $56.21 per share Value used for 9,986-share tax-withholding transaction
Shares held after transaction 435,400 shares Class A Common Stock directly held after Form 4 transaction
restricted stock units financial
"resulting from the vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Section 16b-3(e) regulatory
"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability"
tax withholding obligations financial
"in exchange for the Issuer's agreement to pay federal and state tax withholding obligations"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Budge James

(Last)(First)(Middle)
C/O HINGE HEALTH, INC.
455 MARKET STREET, SUITE 700

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/01/2026F(1)9,986D$56.21435,400D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.
/s/ James Budge06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Hinge Health (HNGE) CFO James Budge report in this Form 4?

Hinge Health CFO James Budge reported a tax-withholding disposition of 9,986 Class A shares. The shares were cancelled so the company could pay his federal and state tax obligations from vesting restricted stock units, leaving him with 435,400 shares directly held.

Was the Hinge Health (HNGE) CFO’s Form 4 transaction an open-market sale?

The Form 4 transaction was not an open-market sale. It was a tax-withholding disposition under Section 16b-3(e), where 9,986 shares were relinquished and cancelled so Hinge Health could satisfy James Budge’s tax obligations arising from vesting restricted stock units.

How many Hinge Health (HNGE) shares did the CFO dispose of for tax withholding?

James Budge disposed of 9,986 shares of Hinge Health Class A common stock. The shares, valued at $56.21 each, were surrendered and cancelled in exchange for the company paying his related federal and state tax withholding obligations from vested restricted stock units.

How many Hinge Health (HNGE) shares does the CFO hold after this Form 4?

After the reported transaction, James Budge directly holds 435,400 shares of Class A common stock. This figure reflects his position following the 9,986-share tax-withholding disposition tied to the vesting of restricted stock units, as disclosed in the Form 4 filing footnote.

What is Section 16b-3(e) treatment in the Hinge Health (HNGE) Form 4 footnote?

The footnote describes an exempt transaction under Section 16b-3(e). Shares were delivered or withheld to pay tax liabilities from vesting restricted stock units, and all 9,986 shares reported as disposed were cancelled in exchange for Hinge Health paying the CFO’s tax withholding obligations.